Research article · 12 Jun 2025
Conference abstractPublished 2017
Study of the interactions of polymeric nanoparticles with model lung surfactant
University of Calgary, Canada
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The pulmonary route offers many advantages for drug delivery such as the high surface area and the close proximity to the blood circulation. The air-blood barrier of the alveoli in the lungs is around 500 nm thick. Above the epithelium cells of the alveoli lies a thin aqueous layer with a thickness of 50-80 nm. A monolayer of phospholipids, natural lipids and few proteins called the lung surfactant (LS) adsorbs onto this aqueous film. The major phospholipid classes include phosphatidylcholines and phosphatidylglycerols. One of the main roles of the LS is to reduce the surface tension experienced in the lungs during breathing cycles in order to prevent lung collapse. From the perspective of pulmonary drug delivery, the LS is the first point of interaction for the drug carriers. With the advancements of nanomedicine, nanoparticles (NPs) became highly relevant as novel drug delivery systems. In particular, there is a great scientific interest for the use of biodegradable NPs for pulmonary delivery route. The objective of our work is to develop a biomimetic model of the LS and then study the effects upon interaction with NPs. Therefore, we focused on understanding the mechanism of interaction between biodegradable polymeric NPs with the biomimetic model of the LS and test whether the stability and lateral architecture of LS is affected. These measurements are done by using Langmuir monolayers at the airwater interface and imaged using Brewster angle microscopy. Results showed that the film stability upon compression is not affected, but there are significant changes in the lateral domain organization of the LS upon NP addition. This work is significant because it helps understand the mechanism of NP-LS interaction and will provide an in-vitro screening approach to assess nanotoxicology.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Weiam Daear”
- BylineArticles whose byline prints “Patrick Lai”
- BylineArticles whose byline prints “Elmar J Prenner”
